Meal timing and anthropometric and metabolic outcomes: a systematic review and meta-analysis
Liu HY, Eso AA, Cook N, et al.
JAMA Netw Open. 2024;7(11):e2442163.
Leggi
Body weight variability as a predictor of cardiovascular outcomes in type 1 diabetes: a nationwide cohort study
Prattichizzo F, Veronesi V, Rigoni M, et al.
Diabetes Obes Metab. Pub. online 28 Oct 2024.
Leggi
Type 1 diabetes in care homes: a practical guide on management
Sinclair AJ, Bellary S, Middleton A, et al.
Diabet Med. 2024:e15457.
Leggi
A mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: a randomised controlled trial
Krebs JD, Parry-Strong A, Braakhuis A, et al.
Diabetes Obes Metab. Pub. online 29 Oct 2024.
Leggi
Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial
Hostrup PE, Schmidt T, Hellsten SB, et al.
Diabetologia. Pub. online 28 Oct 2024.
Leggi
Smoking cessation and incident cardiovascular disease
Cho JH, Shin SY, Kim H, et al.
JAMA Netw Open. 2024;7(11):e2442639.
Leggi
Pathophysiology of vascular ageing and the effect of novel cardio-renal protective medications in preventing progression of chronic kidney disease in people living with diabetes
Fountoulakis N, Miyamoto Y, Pavkov ME, et al.
Diabet Med. 2024:e15464.
Leggi
Once-weekly semaglutide in persons with obesity and knee osteoarthritis
Bliddal H, Bays H, Czernichow S, et al.
N Engl J Med. 2024 Oct 31;391(17):1573-1583
Leggi
FDA: Preventing Damage to Wearable Diabetes Devices During Imaging and Radiation Procedures
15/10/2024
Leggi
European Society for the Study of Obesity (EASO) Position Statement on medical nutrition therapy for the management of individuals with overweight or obesity and cancer
Muscogiuri G, Barrea L, Bettini S, et al.
Obes Facts. 2024:1-37.
Leggi